Viewing data from:

CARBOPROST TROMETHAMINE

ANDA

CARBOPROST TROMETHAMINE | A219529 | SOMERSET THERAPEUTICS LLC

1 strength0 unique patents0 unique exclusivities

Reference Listed Drug: HEMABATE(TE code: AP)

API Supply Chain5 active DMFs

5 active API suppliers hold Drug Master Files for this ingredient.

MSN LABORATORIES PRIVATE LTDCARBOPROST TROMETHAMINE USP [ROUTE CODE "CE"]

DMF 278652014

CHIROGATE INTERNATIONAL INCCARBOPROST TROMETHAMINE

DMF 338072019

EUROAPI HUNGARY LTDCARBOPROST TROMETHAMINE

DMF 354122021

TIEN (TIANJIN) PHARMACEUTICAL CO LTDCARBOPROST TROMETHAMINE

DMF 363732021

BRIGHTGENE BIO-MEDICAL TECHNOLOGY CO LTDCARBOPROST TROMETHAMINE

DMF 374222022

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (1)

#001 — EQ 0.25MG BASE/ML

0 patents0 exclusivities▴

INJECTABLE;INJECTION | Approved: May 27, 2026

No patent or exclusivity listings for this strength.

Change History (1)

Recent changes detected for this application.

ADDED7/1/2026

Somerset Theraps LLC received FDA approval for Carboprost Tromethamine (NDA 219529, Supplement 001).

New: New record